This week's View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including key points from the American College of Physicians on the antibody response and role in conferring natural immunity after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and summaries of articles on whether ABO and rhesus blood groups are associated with risk of SARS-CoV-2 infection and severe COVID-19 and the characteristics, diagnostics, and outcomes of patients with acute ischemic stroke and COVID-19 in the United States.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: COVID-19 Hub, Prevention

Keywords: EaglesEyeView, Cardiovascular Diseases, Coronavirus, Coronavirus Infections, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, COVID-19, ACC COVID-19 Podcast, ABO Blood-Group System, Antibodies, Neutralizing, Antibody Formation, Brain Ischemia, Diagnostic Tests, Routine, Endovascular Procedures, Ethnic Groups, Immunity, Innate, Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Insurance Coverage, N-Acetylneuraminic Acid, Patient Discharge, Polymerase Chain Reaction, Primary Prevention, Reverse Transcriptase Polymerase Chain Reaction, Rh-Hr Blood-Group System, Risk Assessment, RNA, Viral, Secondary Prevention, Stroke, Time-to-Treatment, Vascular Diseases

< Back to Listings